Antidote treatment
Ended Awarded
- Contract number
- SPE2DP26F1088
- Awardee
-
Meridian Medical Technologies, LLC UEI VBM4PLZ9VBC4
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $16,411,500
Award facts
- Contract value 100% obligated
- $16,411,500.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Available for Competition Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- St. Louis, MO 63146, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $16,411,500 |
About this award
The Defense Logistics Agency's Medical Supply Chain division awarded a $16.41M firm-fixed-price delivery order to Meridian Medical Technologies, LLC for antidote treatment products, with performance extending through September 9, 2026. Meridian, a wholly-owned Pfizer subsidiary based in St. Louis, Missouri, specializes in manufacturing medical countermeasures and autoinjector devices, particularly DuoDote autoinjectors containing atropine and pralidoxime chloride for treating nerve agent exposure. This delivery order was issued without a small business set-aside designation, reflecting Meridian's established position as a large contractor in the federal medical countermeasures marketplace.
Meridian maintains a substantial federal contracting footprint across multiple agencies responsible for national preparedness and chemical-biological defense, including the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response, the Department of State, and the U.S. Marshals Service. The company currently operates under two primary indefinite delivery vehicles: the MANDRAKE 3.0 IDIQ contract with the Department of State ($100M ceiling, five-year term through September 2025) and an Other Transaction IDV with the Department of Defense's Joint Program Executive Office for Chemical and Biological Defense ($1M ceiling). Recent significant awards include a $129.7M firm-fixed-price contract from HHS ASPR in September 2024 for supplying DuoDote autoinjectors to the Strategic National Stockpile.
Quick answers
Who was awarded contract SPE2DP26F1088?
SPE2DP26F1088 was awarded to Meridian Medical Technologies, LLC by Medical Supply Chain (Troop Support) on December 8, 2025.
How much is contract SPE2DP26F1088 worth?
The government has obligated $16,411,500 on SPE2DP26F1088.
Is contract SPE2DP26F1088 an order under another contract?
Yes. SPE2DP26F1088 is a delivery order under SPE2DP26D0001, an indefinite delivery contract.
Was contract SPE2DP26F1088 competed?
The extent of competition for SPE2DP26F1088 was not available for competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award